Toth Financial Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-300
Closed -$22K – 750
2021
Q3
$22K Hold
300
– – ﹤0.01% 384
2021
Q2
$28K Hold
300
– – ﹤0.01% 335
2021
Q1
$27K Buy
300
+200
+200% +$19.8K ﹤0.01% 346
2020
Q4
$9K Buy
+100
New +$7.97K ﹤0.01% 414

Other funds holding ARKG

Toth Financial Advisory's ARKG Position: Q4 2021 in Review

Toth Financial Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 300 shares — an estimated $22K sold.

Toth Financial Advisory first reported a position in ARKG in Q4 2020 and held it in 4 quarters. The position peaked at $28K in Q2 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Toth Financial Advisory reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Toth Financial Advisory sold 300 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $22K.
  • Toth Financial Advisory first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 4 quarters.
  • Toth Financial Advisory's ARK Genomic Revolution ETF position peaked at $28K in Q2 2021.
  • 462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Toth Financial Advisory's 13F filing for Q4 2021, filed 31 Jan 2022.